Alignment Healthcare, Inc.
8.06USD
-0.3700 (-4.39%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on ALHC.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 1.4B | 1.8B | 2.7B | 3.9B | 5.2B | 6.5B |
| Q1 | 345.3M | 434.8M | 628.6M | 926.9M | 1.2B | — |
| Q2 | 366.2M | 456.9M | 681.3M | 1.0B | 1.3B | — |
| Q3 | 360.0M | 450.2M | 692.4M | 993.7M | 1.3B | — |
| Q4 | 360.1M* | 459.0M* | 701.2M* | 1.0B* | 1.3B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | -.830 | -.790 | -.670 | .000 | .453 | .650 |
| Q1 | -.021 | -.200 | -.250 | -.050 | .050 | — |
| Q2 | -.060 | -.150 | -.130 | .070 | .170 | — |
| Q3 | -.220 | -.190 | -.140 | .020 | .043 | — |
| Q4 | -.314* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| -.254* |
| -.163* |
| -.056* |
| .035 |
| — |
Debt level and coverage